Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis

NCT: NCT05847751 · ACTIVE_NOT_RECRUITING

NCT IDNCT05847751
StatusACTIVE_NOT_RECRUITING
Start Date2024-03-06
Completion2026-07
SponsorCeric Sàrl (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this study is to evaluate the ACURATE Neo2 in the Middle East population with severe, symptomatic aortic stenosis.

Frequently Asked Questions

What is The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis?

The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis is a clinical trial registered under NCT05847751. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05847751?

The current status of NCT05847751 (The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis) is: ACTIVE_NOT_RECRUITING.

When did The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis start?

The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis started on 2024-03-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑